Skip to content

Prevention of Caries in Head and Neck Cancer Survivors Who Underwent Radiotherapy

Prevention of Caries in Head and Neck Cancer Survivors Who Underwent Radiotherapy: a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06308796
Acronym
RADIOCARIES
Enrollment
40
Registered
2024-03-13
Start date
2023-04-01
Completion date
2026-03-31
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries,Dental, Head and Neck Cancer, Radiotherapy; Complications

Brief summary

One of the long-term side effects of head and neck radiotherapy (RT) is radiation-induced tooth decay. Hyposalivation, associated with radiation therapy, further increases caries susceptibility and caries progression, due to the lack of salivary protective effects and of tooth minerals useful for remineralization processes, especially calcium phosphate (CaP). Dental extractions that could be required in case of severe tooth decay expose the patient to the risk of osteoradionecrosis of the jaws (i.e. the necrosis of the bone tissue following a local trauma, including surgical trauma). This protocol aims at verifying the effectiveness of CaP mousse in the prevention of carious lesions, added to topical fluoride. A randomized controlled clinical trial will be performed comparing CaP + fluoride treatment versus no treatment in head and neck cancer patients, who received radiotherapy. The hypothesis is that CaP, which is lacking in the mouth of these patients due to hyposalivation, can combine with fluoride to promote remineralization, reducing the risk of carious lesions.

Interventions

OTHERApplication of CaP dental mousse

Application of calcium phosphate (CaP) mousse on dental surfaces at home, once a day for 3 months; followed, as maintenance, once a day for just one week a month.

Sponsors

University of Milan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* previous head and neck radiotherapy for oncological treatment

Exclusion criteria

* complete edentulism * pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Number of new cavitated caries per each patient (incidence of caries)Assessment every 3 months up to 2 yearsIdentification of new carious lesion using International Caries Detection and Assessment System from score 0 initial lesions to 6 large cavitated lesions (ICDAS; 4-6)

Secondary

MeasureTime frameDescription
Number of patients with a diagnosis of osteoradionecrosis (incidence of osteoradionecrosis)Assessment every 3 months up to 2 yearsNumber of new areas of bone necrosis
Number of dental surfaces with caries or filling, and missed teethAssessment every 3 months up to 2 yearsRecording of the diseased, missed, filled surfaces (DMFS) index
Number of extracted teeth per patient (incidence of extracted teeth)Assessment every 3 months up to 2 yearsNumber of new teeth extracted
Rate of dental surface with plaque per patientAssessment every 3 months up to 2 yearsRecording of full mouth plaque score (FMPS) (from 0 no plaque to 100% all dental surfaces with plaque)
Rate of bleeding gingival sites per patientAssessment every 3 months up to 2 yearsRecording of full mouth bleeding score (FMPS) (from 0 no plaque to 100% all gingival sites bleeding)
Rate of dentinal hypersensitivity per patientAssessment every 12 months up to 2 yearsDentine Hypersensitivity Experience Questionnaire: the higher the score, the greater the impact of dentin sensitivity on daily life (items have coded responses on 7-point Likert scales: 1 = strongly disagree, 2 = disagree, 3 = agree a little, 4 = neither agree nor disagree, 5 = disagree a little, 6 = disagree and 7 = strongly disagree; a total score is then calculated)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026